OS Therapies Incorporated
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OSTX and other ETFs, options, and stocks.About OSTX
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases.
CEOPaul A. Romness
CEOPaul A. Romness
Employees5
Employees5
HeadquartersGrasonville, Maryland
HeadquartersGrasonville, Maryland
Founded2018
Founded2018
Employees5
Employees5
OSTX Key Statistics
Market cap51.41M
Market cap51.41M
Price-Earnings ratio-1.81
Price-Earnings ratio-1.81
Dividend yield—
Dividend yield—
Average volume519.56K
Average volume519.56K
High today$1.55
High today$1.55
Low today$1.40
Low today$1.40
Open price$1.54
Open price$1.54
Volume256.72K
Volume256.72K
52 Week high$7.00
52 Week high$7.00
52 Week low$1.12
52 Week low$1.12
Stock Snapshot
As of today, OS Therapies Incorporated(OSTX) shares are valued at $1.48. The company's market cap stands at 51.41M, with a P/E ratio of -1.81.
As of 2025-12-30, OS Therapies Incorporated(OSTX) stock has fluctuated between $1.40 and $1.55. The current price stands at $1.48, placing the stock +5.6% above today's low and -4.6% off the high.
OS Therapies Incorporated(OSTX) shares are trading with a volume of 256.72K, against a daily average of 519.56K.
During the past year, OS Therapies Incorporated(OSTX) stock moved between $1.12 at its lowest and $7.00 at its peak.
During the past year, OS Therapies Incorporated(OSTX) stock moved between $1.12 at its lowest and $7.00 at its peak.
People also own
Based on the portfolios of people who own OSTX. This list is generated using Robinhood data, and it’s not a recommendation.